Agios Pharmaceuticals (AGIO) Stock News
$AGIO · NASDAQ · 2 stories in 30 daysBORSA has published 2 stories on Agios Pharmaceuticals (AGIO) in the past 30 days. BORSA’s news read on AGIO is bearish at 38/100, unchanged over 24 hours, based on 2 company events over the past 7 days. AGIO last closed at $30.55 on Oct 30, down 17.43% over five sessions and down 5.94% over the past month. Agios Pharmaceuticals’ next earnings report is scheduled for Thursday, Nov 5 before the open.
The wire on $AGIO
newest first · updated · direct subject stories onlyAgios Pharmaceuticals dropped 19% to $30.26 after the FDA extended the review goal date for mitapivat to Feb. 1. The extension follows an FDA request for additional REMS-related information. Agios said the benefit-risk profile remains unchanged.
bearish 20 · impact 60HC Wainwright & Co. initiated coverage of Agios Pharmaceuticals with a Buy rating. The move signals a positive view on the biotech stock.
bullish 60 · impact 20The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.